The Federal Deposit Insurance Corporation (FDIC) has approved a proposal to roll back a Biden-era policy that increased scrutiny on large bank mergers. The decision, announced Monday, reinstates the pre-2024 merger policy while the agency reassesses its review process.
This move, led by the Republican-controlled FDIC, reverses stricter regulations imposed by the previous Democratic leadership, which aimed to heighten oversight of mergers involving large financial institutions. The 2024 policy required public hearings for bank mergers resulting in assets exceeding $50 billion and mandated heightened financial stability reviews for those surpassing $100 billion.
The rollback aligns with a broader shift under the pro-business Trump administration, which contrasts with Biden-era policies that pushed for tougher regulatory scrutiny on corporate mergers. Banks have long criticized the merger approval process as overly complex and opaque. The Bank Policy Institute, representing large financial firms, opposed the 2024 policy, arguing it created regulatory uncertainty and exceeded Congress’s intended oversight.
By reverting to the prior framework, the FDIC aims to provide a more predictable path for bank mergers while conducting a comprehensive evaluation of its policies.


Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Paul Atkins Emphasizes Global Regulatory Cooperation at Fintech Conference
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
ICE Blocked From Entering Ecuador Consulate in Minneapolis During Immigration Operation
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Pentagon Ends Military Education Programs With Harvard University
Trump Rejects Putin’s New START Extension Offer, Raising Fears of a New Nuclear Arms Race
U.S. Eases Venezuela Oil Sanctions to Boost American Investment After Maduro Ouster
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Trump Administration Sued Over Suspension of Critical Hudson River Tunnel Funding
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Illinois Joins WHO Global Outbreak Network After U.S. Exit, Following California’s Lead
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit 



